Sandesh Mahatme insider trades

Open-market stock purchases and sales by Sandesh Mahatme, Unknown at CRISPR Therapeutics AG, from SEC Form 4 filings since Nov 5, 2012.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -50%.

Recent trades

DateStockTradeValue
Jun 5, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Dec 5, 2025VOR Vor Biopharma IncSold (not open market)—
Dec 5, 2025VOR Vor Biopharma IncBought (not open market)—

Companies traded

  • CRSP CRISPR Therapeutics AG: other filings, last Jun 5, 2026
  • VOR Vor Biopharma Inc: other filings, last Dec 5, 2025
  • AGLE Aeglea BioTherapeutics, Inc: other filings, last Jun 7, 2022
  • SRPT Sarepta Therapeutics, Inc: 1 buy, 6 sales, last Jul 8, 2020
  • FLXN Flexion Therapeutics Inc: other filings, last Jun 10, 2020

Get free alerts when Sandesh Mahatme files a new trade →